Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 9, 2005, Pages 1129-

  Zhernosekov, K ^a   Aschoff, P ^c   Filosofov, D ^b   Jahn, M ^a   Jennewein, M ^a   Adrian, H J ^c   Bihl, H ^c   Rosch F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b JOINT INSTITUTE FOR NUCLEAR RESEARCH   (Russian Federation)

^c KLINIKUM STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 67; PENTETREOTIDE; PENTETREOTIDE IN 111; PEPTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR 2;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG RECEPTOR BINDING; DRUG UPTAKE; HUMAN; IN VIVO STUDY; INJECTION; ISOTOPE LABELING; KIDNEY; LYMPH NODE METASTASIS; MALE; MESENTERY LYMPH NODE; RECEPTOR UPREGULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMALL INTESTINE CARCINOMA; TUMOR;

AGED; HUMANS; INTESTINAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 25144446257     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1864-2     Document Type: Article

References (2)

1. 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751-7
2. 111In-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003;5:42-8